| Display title | Chemistry:Suxethonium chloride |
| Default sort key | Suxethonium chloride |
| Page length (in bytes) | 4,605 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 545064 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Raymond Straus |
| Date of page creation | 11:57, 6 March 2023 |
| Latest editor | imported>Raymond Straus |
| Date of latest edit | 11:57, 6 March 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Suxethonium (trade name: Brevidil-E) is a depolarising muscle relaxant which is presented as a dry powder in an ampoule. This is re-constituted with sterile water prior to use. It is available in Australia as a schedule 4 drug, and the US. |
